Enwei Pharmaceutical Co., Ltd. (SHE:301331)
China
· Delayed Price · Currency is CNY 28.57
+0.72 (2.59%)
At close: Mar 10, 2026
Enwei Pharmaceutical Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Cash & Equivalents | 319.61 | 370.27 | 236.12 | 341.58 | 64.25 | 63.02 | Upgrade
|
| Trading Asset Securities | 205.33 | 144.72 | 157.16 | 236.56 | 14.4 | 14.4 | Upgrade
|
| Cash & Short-Term Investments | 524.94 | 515 | 393.28 | 578.14 | 78.65 | 77.42 | Upgrade
|
| Cash Growth | 5.91% | 30.95% | -31.97% | 635.07% | 1.59% | 25.24% | Upgrade
|
| Accounts Receivable | 264.6 | 296.53 | 265 | 245.28 | 192.91 | 220.59 | Upgrade
|
| Other Receivables | 4.75 | 3.69 | 3.99 | 4.17 | 3.98 | 3.43 | Upgrade
|
| Receivables | 269.35 | 300.22 | 268.98 | 249.45 | 196.89 | 224.02 | Upgrade
|
| Inventory | 114.49 | 115.55 | 107.37 | 104.65 | 110.01 | 78.34 | Upgrade
|
| Other Current Assets | 28.48 | 21.27 | 17.23 | 25.06 | 28.21 | 29.01 | Upgrade
|
| Total Current Assets | 937.26 | 952.04 | 786.86 | 957.29 | 413.77 | 408.79 | Upgrade
|
| Property, Plant & Equipment | 268.44 | 246.55 | 231.12 | 240 | 241.77 | 224.15 | Upgrade
|
| Long-Term Investments | - | 0.37 | 0.37 | 0.35 | 0.42 | 0.85 | Upgrade
|
| Goodwill | 100.55 | 100.55 | 100.55 | 100.55 | 100.55 | 100.55 | Upgrade
|
| Other Intangible Assets | 121.31 | 133.37 | 148.04 | 42.08 | 47.45 | 52.26 | Upgrade
|
| Long-Term Deferred Tax Assets | 5.24 | 4.64 | 3.05 | 1.8 | 1.74 | 1.83 | Upgrade
|
| Long-Term Deferred Charges | 7.76 | 8.7 | 10.68 | 16.83 | 18.28 | 19.76 | Upgrade
|
| Other Long-Term Assets | 56.15 | 58.3 | 56.81 | 47.18 | 45.11 | 40.68 | Upgrade
|
| Total Assets | 1,497 | 1,505 | 1,337 | 1,406 | 869.09 | 848.86 | Upgrade
|
| Accounts Payable | 46.7 | 49.49 | 30.94 | 36.88 | 33.64 | 45.95 | Upgrade
|
| Accrued Expenses | 26.79 | 132.83 | 141.69 | 141.02 | 128.52 | 147.3 | Upgrade
|
| Current Portion of Long-Term Debt | 11.38 | 10.09 | - | - | - | - | Upgrade
|
| Current Portion of Leases | - | 1.27 | 0.88 | - | - | - | Upgrade
|
| Current Income Taxes Payable | 9.47 | 6.52 | 10.21 | 11.23 | 8.19 | 12.69 | Upgrade
|
| Current Unearned Revenue | 24.48 | 24.61 | 14.01 | 28.15 | 16.15 | 13.89 | Upgrade
|
| Other Current Liabilities | 92.41 | 13.6 | 12.04 | 10.31 | 12.73 | 14.35 | Upgrade
|
| Total Current Liabilities | 211.22 | 238.42 | 209.77 | 227.58 | 199.22 | 234.18 | Upgrade
|
| Long-Term Debt | 180 | 185 | - | - | - | - | Upgrade
|
| Long-Term Leases | 0.71 | 1.52 | 0.46 | - | - | - | Upgrade
|
| Long-Term Unearned Revenue | 8.22 | 9.96 | 11.92 | 14.05 | 15.88 | 18.06 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 12.91 | 11.96 | 12.17 | 11.45 | 11.74 | 10.1 | Upgrade
|
| Total Liabilities | 413.06 | 446.86 | 234.31 | 253.08 | 226.84 | 262.34 | Upgrade
|
| Common Stock | 102.89 | 102.89 | 70.14 | 70.14 | 52.6 | 52.6 | Upgrade
|
| Additional Paid-In Capital | 646.3 | 638.71 | 671.51 | 664.63 | 239.22 | 239.22 | Upgrade
|
| Retained Earnings | 393.64 | 375.25 | 392.32 | 418.23 | 350.43 | 294.7 | Upgrade
|
| Treasury Stock | -59.18 | -59.18 | -30.78 | - | - | - | Upgrade
|
| Total Common Equity | 1,084 | 1,058 | 1,103 | 1,153 | 642.25 | 586.52 | Upgrade
|
| Shareholders' Equity | 1,084 | 1,058 | 1,103 | 1,153 | 642.25 | 586.52 | Upgrade
|
| Total Liabilities & Equity | 1,497 | 1,505 | 1,337 | 1,406 | 869.09 | 848.86 | Upgrade
|
| Total Debt | 192.09 | 197.88 | 1.34 | - | - | - | Upgrade
|
| Net Cash (Debt) | 332.85 | 317.12 | 391.94 | 578.14 | 78.65 | 77.42 | Upgrade
|
| Net Cash Growth | 13.33% | -19.09% | -32.21% | 635.07% | 1.59% | 49.41% | Upgrade
|
| Net Cash Per Share | 3.33 | 3.14 | 3.81 | 6.85 | 1.01 | 1.06 | Upgrade
|
| Filing Date Shares Outstanding | 101.08 | 101.08 | 100.99 | 103.8 | 77.85 | 77.85 | Upgrade
|
| Total Common Shares Outstanding | 101.08 | 101.08 | 102.76 | 103.8 | 77.85 | 77.85 | Upgrade
|
| Working Capital | 726.04 | 713.62 | 577.09 | 729.7 | 214.55 | 174.61 | Upgrade
|
| Book Value Per Share | 10.72 | 10.46 | 10.74 | 11.11 | 8.25 | 7.53 | Upgrade
|
| Tangible Book Value | 861.79 | 823.74 | 854.59 | 1,010 | 494.25 | 433.71 | Upgrade
|
| Tangible Book Value Per Share | 8.53 | 8.15 | 8.32 | 9.73 | 6.35 | 5.57 | Upgrade
|
| Buildings | - | 289.03 | 287.63 | 275.1 | 274.06 | 239.09 | Upgrade
|
| Machinery | - | 301.77 | 302.77 | 271.99 | 263.51 | 237.07 | Upgrade
|
| Construction In Progress | - | 40.37 | 8.82 | 35.68 | 23.84 | 46.75 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.